SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, DSPG, LMRK, TRIL; Shareholders are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: ADTRAN, Inc. concerning potential...
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
ABBVie today announced that it has submitted applications seeking approval for upadacitinib and 45 mg ) for the treatment of...
Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT Study
TNBC Severely Impacts Patient Health-Related Quality of Life, with Poorer Outcomes for Those with Metastatic Disease vs. Other Breast Cancer...
New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regardless of Initial HR/HER2 Status
Patients Whose Disease Changed to Triple-Negative Had Similar Positive Outcomes to Overall Metastatic TNBC Population in ASCENT Study – –...
Five-Year Data from CheckMate -214 Show Opdivo Plus Yervoy Demonstrates Longest Median Overall Survival Currently Reported in Phase 3 Trial of Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Nearly half of patients treated with the dual immunotherapy combination were alive at five years from the start of therapy...
LUMAKRAS Combined With Vectibix® Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Amgen today announced the first combination study results from the Phase 1b 2 CodeBreaK 101 study, the most comprehensive global...
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
Aurinia Pharmaceuticals Inc. today announced that members of the senior management team will present at the following upcoming virtual investor...
